Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer.
Saved in:
| Title: | Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer. |
|---|---|
| Authors: | Crossman BE; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Harmon RL; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Iida M; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Adams JM; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Lin CY; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Glitchev CE; Department of Human Oncology, University of Wisconsin, Madison, WI, United States., Juang TD; Department of Biomedical Engineering, University of Wisconsin, Madison, WI, United States., Kerr SC; School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, United States., Alexandridis RA; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, United States., Hyun M; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, United States., Yang DT; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States., Kang I; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Salgia R; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Wheeler DL; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.; School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2025 May 05; Vol. 15, pp. 1579214. Date of Electronic Publication: 2025 May 05 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40391157 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Crossman+BE%22">Crossman BE</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Harmon+RL%22">Harmon RL</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Iida+M%22">Iida M</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Adams+JM%22">Adams JM</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Lin+CY%22">Lin CY</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Glitchev+CE%22">Glitchev CE</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Juang+TD%22">Juang TD</searchLink>; Department of Biomedical Engineering, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Kerr+SC%22">Kerr SC</searchLink>; School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Alexandridis+RA%22">Alexandridis RA</searchLink>; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Hyun+M%22">Hyun M</searchLink>; Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Yang+DT%22">Yang DT</searchLink>; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Kang+I%22">Kang I</searchLink>; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Salgia+R%22">Salgia R</searchLink>; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Wheeler+DL%22">Wheeler DL</searchLink>; Department of Human Oncology, University of Wisconsin, Madison, WI, United States.; School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin, Madison, WI, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 May 05; Vol. 15, pp. 1579214. <i>Date of Electronic Publication: </i>2025 May 05 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40391157 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1579214 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1579214 Titles: – TitleFull: Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Crossman BE – PersonEntity: Name: NameFull: Harmon RL – PersonEntity: Name: NameFull: Iida M – PersonEntity: Name: NameFull: Adams JM – PersonEntity: Name: NameFull: Lin CY – PersonEntity: Name: NameFull: Glitchev CE – PersonEntity: Name: NameFull: Juang TD – PersonEntity: Name: NameFull: Kerr SC – PersonEntity: Name: NameFull: Alexandridis RA – PersonEntity: Name: NameFull: Hyun M – PersonEntity: Name: NameFull: Yang DT – PersonEntity: Name: NameFull: Kang I – PersonEntity: Name: NameFull: Salgia R – PersonEntity: Name: NameFull: Wheeler DL IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 05 Text: 2025 May 05 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |